Novo Nordisk Sues Telehealth Firm Over Compounded GLP-1 Weight Loss Drugs
Novo Nordisk filed a patent infringement lawsuit against Hims & Hers over compounded versions of Wegovy. The legal action follows the telehealth company's announcement of a $49 oral pill, which was withdrawn after FDA warnings.